These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 32655732)

  • 1. The Impact of Cannabidiol on Psychiatric and Medical Conditions.
    Oberbarnscheidt T; Miller NS
    J Clin Med Res; 2020 Jul; 12(7):393-403. PubMed ID: 32655732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science.
    Marinotti O; Sarill M
    J Diet Suppl; 2020; 17(5):517-526. PubMed ID: 32543253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
    Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
    JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current legal status of medical marijuana and cannabidiol in the United States.
    Alharbi YN
    Epilepsy Behav; 2020 Nov; 112():107452. PubMed ID: 32956945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Cannabidiol Safety: A Review.
    Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
    Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
    McFadden BR; Malone T
    Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrative Medicine: Cannabis and Cannabis-Related Drugs.
    Moss DA; Hawks MK; Snyder MJ; Crawford PF
    FP Essent; 2021 Jun; 505():28-34. PubMed ID: 34128629
    [No Abstract]   [Full Text] [Related]  

  • 9. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicians' Guide to Cannabidiol and Hemp Oils.
    VanDolah HJ; Bauer BA; Mauck KF
    Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid therapy in epilepsy.
    Billakota S; Devinsky O; Marsh E
    Curr Opin Neurol; 2019 Apr; 32(2):220-226. PubMed ID: 30676535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
    Koturbash I; MacKay D
    J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
    Miller OS; Elder EJ; Jones KJ; Gidal BE
    Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Status of Cannabidiol in the United States: A Perspective.
    Corroon J; Kight R
    Cannabis Cannabinoid Res; 2018; 3(1):190-194. PubMed ID: 30283822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
    Brighenti V; Protti M; Anceschi L; Zanardi C; Mercolini L; Pellati F
    J Pharm Biomed Anal; 2021 Jan; 192():113633. PubMed ID: 33039911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabidiol conundrum: potential benefits and risks of cannabidiol products for children.
    Singer L; Tokish H; Park F; Campisi C; Milanaik RL
    Curr Opin Pediatr; 2020 Feb; 32(1):198-205. PubMed ID: 31833952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol - therapeutic and legal aspects.
    Vlad RA; Hancu G; Ciurba A; Antonoaea P; Rédai EM; Todoran N; Silasi O; Muntean DL
    Pharmazie; 2020 Oct; 75(10):463-469. PubMed ID: 33305718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.